Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2020-08-01
Schriftenreihe:Vaccines
Schlagworte:
hepatocellular carcinoma
PD-L1
CTLA-4
oncolytic viruses
antigen peptide vaccines
DC vaccines
Online Zugang:https://www.mdpi.com/2076-393X/8/3/447
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge